Abou El Hassan, M. A. I., Rabelink, M. J. W. E., van der Vijgh, W. J. F., Bast, A., & Hoeben, R. C. (2003). A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro. Nature Publishing Group.
Chicago-стиль цитированияAbou El Hassan, M A I., M J W E. Rabelink, W J F. van der Vijgh, A. Bast, and R C. Hoeben. A Comparative Study between Catalase Gene Therapy and the Cardioprotector Monohydroxyethylrutoside (MonoHER) in Protecting against Doxorubicin-induced Cardiotoxicity in Vitro. Nature Publishing Group, 2003.
MLA-цитированиеAbou El Hassan, M A I., et al. A Comparative Study between Catalase Gene Therapy and the Cardioprotector Monohydroxyethylrutoside (MonoHER) in Protecting against Doxorubicin-induced Cardiotoxicity in Vitro. Nature Publishing Group, 2003.